Literature DB >> 11862616

PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1.

Edmund Derrington1, Caroline Gabus, Pascal Leblanc, Jonas Chnaidermann, Linda Grave, Dominique Dormont, Wieslaw Swietnicki, Manuel Morillas, Daniel Marck, Pradip Nandi, Jean-Luc Darlix.   

Abstract

The function of the cellular prion protein (PrPC) remains obscure. Studies suggest that PrPC functions in several processes including signal transduction and Cu2+ metabolism. PrPC has also been established to bind nucleic acids. Therefore we investigated the properties of PrPC as a putative nucleic acid chaperone. Surprisingly, PrPC possesses all the nucleic acid chaperoning properties previously specific to retroviral nucleocapsid proteins. PrPC appears to be a molecular mimic of NCP7, the nucleocapsid protein of HIV-1. Thus PrPC, like NCP7, chaperones the annealing of tRNA(Lys) to the HIV-1 primer binding site, the initial step of retrovirus replication. PrPC also chaperones the two DNA strand transfers required for production of a complete proviral DNA with LTRs. Concerning the functions of NCP7 during budding, PrPC also mimices NCP7 by dimerizing the HIV-1 genomic RNA. These data are unprecedented because, although many cellular proteins have been identified as nucleic acid chaperones, none have the properties of retroviral nucleocapsid proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11862616     DOI: 10.1016/s1631-0691(02)01388-4

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  12 in total

1.  Formation of native prions from minimal components in vitro.

Authors:  Nathan R Deleault; Brent T Harris; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

2.  Selective incorporation of polyanionic molecules into hamster prions.

Authors:  James C Geoghegan; Pablo A Valdes; Nicholas R Orem; Nathan R Deleault; R Anthony Williamson; Brent T Harris; Surachai Supattapone
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

Review 3.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

4.  Nucleic acid induced unfolding of recombinant prion protein globular fragment is pH dependent.

Authors:  Alakesh Bera; Pradip K Nandi
Journal:  Protein Sci       Date:  2014-10-28       Impact factor: 6.725

Review 5.  The intriguing prion disorders.

Authors:  K Abid; C Soto
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

Review 6.  Prion protein interactions with nucleic acid: possible models for prion disease and prion function.

Authors:  Abraham Grossman; Brian Zeiler; Victor Sapirstein
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

7.  Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Authors:  Andreina Baj; Alessia Bettaccini; Takuya Nishimura; Takashi Onodera; Antonio Toniolo
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

8.  In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Authors:  Bonto Faburay; Dongseob Tark; Anumantha G Kanthasamy; Juergen A Richt
Journal:  Prion       Date:  2014       Impact factor: 3.931

9.  Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.

Authors:  Victoria A Lawson; Brooke Lumicisi; Jeremy Welton; Dorothy Machalek; Katrina Gouramanis; Helen M Klemm; James D Stewart; Colin L Masters; David E Hoke; Steven J Collins; Andrew F Hill
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

10.  Site-selective probing of cTAR destabilization highlights the necessary plasticity of the HIV-1 nucleocapsid protein to chaperone the first strand transfer.

Authors:  Julien Godet; Cyril Kenfack; Frédéric Przybilla; Ludovic Richert; Guy Duportail; Yves Mély
Journal:  Nucleic Acids Res       Date:  2013-03-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.